Tango Therapeutics Inc. (TNGX)
NASDAQ · Healthcare
Tango Therapeutics Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 62.4M | 42.1M | 36.5M | 24.9M | 37.0M | 7.7M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -111.3M | -145.6M | -114.2M | -111.1M | -58.2M | -52.2M |
| EBITDA | — | — | — | — | — | — |
| Net Income | -101.6M | -130.3M | -101.7M | -108.2M | -58.2M | -52.0M |
| Per Share Data | ||||||
| EPS (diluted) | $-0.87 | $-1.19 | $-1.08 | $-1.23 | $-0.94 | — |
| Shares Outstanding (dil.) | 116M | 109M | 95M | 88M | 62M | 40M |
Tango Therapeutics Inc. Income Statement — FAQ
Tango Therapeutics Inc. (TNGX) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TNGX's income statement history?
The chart and table above show Tango Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.